Arginase inhibitors and methods of use thereof
US8894970B2 · kind B2 · utility
22Cited by
30References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2011 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Jul 16, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes arginase enzyme inhibitors, compositions comprising these arginase inhibitors, and methods of treating or diagnosing conditions characterized either by abnormally high arginase activity or abnormally low nitric oxide levels in a mammal, comprising administering compositions of the invention to the mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.